Product Information
BEPOTASTINE 1.5% EYE DROP is a generic product labeled by Bausch & Lomb Incorporated, priced at $8.3591 per ML under NDC 24208063010. Its NADAC has been published 262 times since Aug 18, 2021.
FDA first approved this application on Sep 8, 2009. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the bepotastine besilate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
15 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208063010
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
BEPOTASTINE BESILATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022288FDA Approved
9/8/2009
TE Code
AT
On Market Since
5/28/2021
Pharmacological Classes
Price Statistics
The NADAC for BEPOTASTINE 1.5% EYE DROP has been published 262 times since Aug 18, 2021, and over the history we have for it it has declined 76.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.3591 per ML |
|---|---|
| All-time high | $36.0376 (Dec 15, 2021) |
| All-time low | $8.3145 (Jul 22, 2026) |
| 52-week high | $16.1322 |
| 52-week low | $8.3145 |
| Median price | $18.2162 |
| Average price | $20.2935 |
| Largest weekly change | -29.4% (May 18, 2022) |
| Weeks tracked | 262 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BEPOTASTINE 1.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for BEPOTASTINE 1.5% EYE DROP, manufactured by Bausch & Lomb Incorporated, is $8.3591 per ML (NDC 24208063010), effective Aug 19, 2026.
How has the price of BEPOTASTINE 1.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for BEPOTASTINE 1.5% EYE DROP has declined 76.8%. It has been tracked across 262 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for BEPOTASTINE 1.5% EYE DROP?
Since Aug 18, 2021, the NADAC for BEPOTASTINE 1.5% EYE DROP has ranged from a low of $8.3145 (Jul 22, 2026) to a high of $36.0376 (Dec 15, 2021), with a median of $18.2162 per ML.
Are there cheaper alternatives to BEPOTASTINE 1.5% EYE DROP?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BEPOTASTINE 1.5% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures BEPOTASTINE 1.5% EYE DROP?
BEPOTASTINE 1.5% EYE DROP (NDC 24208063010) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.